Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study-Reference-Cited by-同舟云学术

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study

Published:2015-07 Issue: Volume:66-67 Page:84-94
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Han Changsu,Wang Sheng-Min,Kwak Kyung-Phil,Won Wang-Yeon,Lee HwaYoung,Chang Chia Ming,Tang Tze Chun,Pae Chi-Un

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference99 articles.

1. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study;Baldomero;Depress Anxiety,2005

2. Role of lithium augmentation in the management of major depressive disorder;Bauer;CNS Drugs,2014

3. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants;Berman;CNS Spectr,2009

4. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study;Berman;J Clin Psychiatry,2007

5. External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?;Beyer-Westendorf;J Thromb Haemost,2011

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of the Third-Generation Atypical Antipsychotic Aripiprazole (Zylaxera®) for Treatment of Depressive States in Schizophrenia: Efficacy and Safety Study;Psikhiatriya;2023-06-19

2. Rethinking the medication management of major depression;Expert Review of Neurotherapeutics;2023-04-03

3. Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis;Journal of Affective Disorders;2022-04

4. Treatment-Resistant Depression in Poland—Epidemiology and Treatment;Journal of Clinical Medicine;2022-01-18

5. Combination Therapies and Switching of Agents in Depression and Bipolar Disorders;NeuroPsychopharmacotherapy;2022